PHARMACEUTICAL PROFILES CHOOSES QAAD

READING, UNITED KINGDOM -15th June 2007 - AMG IT Systems Ltd. announced today that Pharmaceutical Profiles™, who provide drug development support to most of the top 30 pharmaceutical companies and more than 250 biotechnology companies worldwide, has chosen QAAD as its sole provider for quality data, trending and reporting; enabling them to better meet client and regulatory expectations.

Pharmaceutical Profiles will use QAAD to replace several in-house systems to provide for easier tracking of CAPAs, ensure optimal use of the vast amount of quality data generated within the company and to increase professionalism within its QA group. QAAD will become an integral strategic tool for Pharmaceutical Profiles' plans for business expansion.

Pharmaceutical Profiles, based in Ruddington Fields, U.K., considered several other software providers but felt that none of them offered the solution that met their needs. Their selection was based on the fact that QAAD is highly regarded by a large number of pharmaceutical companies and is fast becoming the industry standard QA software package. "QAAD offered us the best of both worlds---affordability and functionality," said Tracy Saunders, GXP Compliance Manager for Pharmaceutical Profiles. "I've had experience using QAAD in my last role and understand the benefits it could bring to a growing and forward thinking company such as Pharmaceutical Profiles."

QAAD will be deployed within Pharmaceutical Profiles to handle deviation and CAPA tracking, quality trending, metrics and reporting, as well as audit programme management. The software will also provide an integrated solution to a number of quality management issues, which have traditionally been handled using a variety of disparate systems.